A central issue in stem cell biology is to understand the mechanisms that regulate the self-renewal of haematopoietic stem cells (HSCs), which are required for haematopoiesis to persist for the lifetime of the animal 1 . We found that adult and fetal mouse and adult human HSCs express the proto-oncogene Bmi-1. The number of HSCs in the fetal liver of Bmi-1 2/2 mice 2 was normal. In postnatal Bmi-1 2/2 mice, the number of HSCs was markedly reduced. Transplanted fetal liver and bone marrow cells obtained from Bmi-1 2/2 mice were able to contribute only transiently to haematopoiesis. There was no detectable self-renewal of adult HSCs, indicating a cell autonomous defect in Bmi-1 2/2 mice. A gene expression analysis revealed that the expression of stem cell associated genes 3 , cell survival genes, transcription factors, and genes modulating proliferation including p16
Ink4a and p19
Arf was altered in bone marrow cells of the Bmi-1 2/2 mice.
Expression of p16
Ink4a and p19 Arf in normal HSCs resulted in proliferative arrest and p53-dependent cell death, respectively. Our results indicate that Bmi-1 is essential for the generation of self-renewing adult HSCs.
To understand the molecular mechanisms that control the selfrenewal of haematopoietic stem cells (HSCs), we have previously constructed a complementary DNA library using highly purified cells with long-term self-renewal potential 4 and analysed the differential gene expression profile of HSCs 5 . Analysis of genes expressed in HSCs identified Bmi-1, a member of the Polycomb Group (PcG) family linked to malignant transformation, lymphocyte development, neurological development and senescence of fibroblasts 2, [6] [7] [8] . Bmi-1 expression, which declines during haematopoietic development 9 , was detected at both single-cell and ten-cell levels by polymerase chain reaction with reverse transcription (RT-PCR) in mouse fetal liver and adult HSCs as well as human normal and leukaemic stem cells, indicating that HSCs express high levels of Bmi-1 ( Supplementary Fig. 1 ).
The Bmi-1 2/2 mice develop hypocellular bone marrows and die less than 2 months after birth. To determine the function of Bmi-1 in haematopoiesis, Bmi-1 2/2 mice 2 in a C57Bl/Ka.Thy1.1 background 1 were analysed. As reported previously 2 , Bmi-1 2/2 mice have normal numbers of peripheral blood myeloid cells but smaller numbers of lymphocytes, whereas the frequency of colony-forming cells in the bone marrow was normal ( Supplementary Fig. 2 ).
In vertebrates, haematopoiesis is organized as a hierarchy, in which HSCs contribute to haematopoiesis for the life of the animal and give rise to transiently reconstituting multipotent progenitors (MPPs) 1 . To determine whether these mice have normal numbers of stem cells that have lost the ability to make progeny or whether they have a defect in the generation of stem cells, we investigated the frequency of HSCs and MPPs from 4-5-week-old Bmi-1
þ/2 and Bmi-1 2/2 mice by flow cytometry (Fig. 1a, b) . The frequency of HSCs (Thy1.1 low c-kit þ Sca-1 þ Lineage 2 cells) in the bone marrow of heterozygous mice was similar to that of the wildtype littermates (about 0.01% of bone marrow cells). However, the HSC frequency of the Bmi-1 2/2 mice ranged from 0% to 0.013%, with an average of 0.005%. When the total numbers of bone marrow cells were taken into account, Bmi-1 2/2 mice had an average 10-fold (up to 45-fold) less total HSCs as measured by flow cytometry (P ¼ 0.007; Supplementary Fig. 3 (Fig. 1c) . By 10 weeks, the mice reconstituted with Bmi-1 2/2 marrow, but not with wild-type bone marrow, lost nearly all donor-derived mature haematopoietic cells (Fig. 1d) . These results indicate that Bmi-1 might be required for self-renewal and/or maintenance of adult HSCs.
The defect in HSCs in the bone marrow of Bmi-1 2/2 mice could result from an impaired generation of self-renewing fetal and/or adult HSCs, defective stem cell homing, or a defective bone marrow microenvironment. We therefore next examined the HSC compartment in fetal Bmi-1 2/2 mice. As measured by flow cytometry, Bmi-1 2/2 mice had similar numbers of fetal liver cells and an almost identical frequency of fetal liver HSCs
) as their wild-type littermates (Fig. 2a) . Furthermore, the fetal liver HSCs from Bmi-1 2/2 mice migrated normally towards the chemokine SDF-1a, and fetal liver cells expressed normal levels of SDF-1a and its receptor CXCR4, important mediators of HSC homing 11 ( Supplementary Fig. 4 ). letters to nature
Although it is possible that Bmi-1 affects homing by other pathways, these data suggest that the HSC defect in Bmi-1 2/2 bone marrow is not likely to be the result of defective fetal liver HSC migration to the bone marrow.
If the defects in the Bmi-1 2/2 mice were secondary to an abnormal microenvironment, then fetal liver stem cells from these mice would be able to engraft the bone marrow of wild-type mice efficiently. If the defects were in the generation of self-renewing HSCs, then Bmi-1 2/2 fetal liver HSCs would fail to permanently engraft the bone marrow of normal adult mice. To distinguish between these possibilities, lethally irradiated Ly5.2 congenic mice were transplanted with 5 £ 10 5 , 10 6 and 5 £ 10 6 Bmi-1
cells, or 5 £ 10 5 and 10 6 Bmi-1 þ/þ embryonic day 14.5 (E14.5) fetal liver cells. In addition, competitive reconstitution assays were performed with 10 6 fetal liver cells from
mice mixed with 10 6 Ly5.2 bone marrow cells. At 4 weeks after transplantation, Bmi-1 2/2 mice showed reconstitution of T cells and myeloid cells, whereas B-cell reconstitution was greatly decreased (Fig. 2b) . By 8 weeks, virtually no donor-derived cells were detected in recipient bone marrows reconstituted with Bmi-1 2/2 fetal liver cells (Fig. 2c) , suggesting a severe defect in the HSCs' ability to maintain haematopoiesis. At 8 weeks after the original transplant, secondary bone marrow transplants were performed with 10 7 donor cells. Peripheral blood analysis after 6 weeks indicated that there were no detectable Bmi-1 2/2 cells in the mice with secondary transplants (Fig. 2d ). Taken together with the marked decrease in HSC numbers in the bone marrow of the Bmi-1 2/2 mice, these results demonstrate that there is a profound intrinsic defect in the maintenance of self-renewing HSCs in the mutant mice.
To begin to understand the molecular mechanism by which Bmi-1 affects the generation of HSCs, we compared the gene expression profiles of bone marrow mononuclear cells obtained from wild-type and Bmi-1 2/2 mice. Bmi-1 is a member of the PcG family of transcriptional repressors that control development by the regulation of cell growth and differentiation genes 12 . Microarray analysis with bone marrow RNAs isolated from wild-type and Bmi-1 2/2 mice identified several interesting genes (Fig. 3a, b and Supplementary Table 2 ). These include wild-type p53-induced gene 1 (Wig1), tight-junction protein 1 (TJP1) and platelet-activating factor acetylhydrolase isoform 1b (PAF-AHg), all of which are expressed in embryonic, neuronal and haematopoietic stem cells 3 , as well as several transcription factors, signalling proteins and apoptosis inhibitor 6. As reported previously in embryonic fibroblasts, expression of p16 Ink4a and p19
Arf , which are generated by alternative splicing from the Ink4a locus [13] [14] [15] , in adult bone marrow of Bmi-1 2/2 mice was elevated compared with wild-type littermates (Fig. 3a) . A complete list of differentially expressed genes is given in Supplementary Table 3. In contrast with the analysis of the adult bone marrow, a microarray analysis of E14.5 fetal liver cells did not show significant differences in the gene expression by the wild-type and mutant cells (data not shown), which is consistent with the observation that Bmi-1 is not crucial for fetal liver haematopoiesis. Some members of the Hox family are also thought to be targets of Bmi-1. Semiquantitative RT-PCR indicated that expression of Hoxb4, which is important for HSC development 16 , was not altered in Bmi-1 2/2 mice whereas Hoxa9, which functions in cell fate decisions of haematopoietic progenitors 17 , was slightly upregulated in thymus and bone marrow of Bmi-1 2/2 mice ( Supplementary  Fig. 5) .
Next, the effects of the Arf virus, had lost viability as measured by exclusion of a viability dye 7AAD (Fig. 4) . When single viable GFP-positive HSCs were placed in culture medium, 79% of the haematopoietic progenitors infected with the control GFP virus generated more than 50 cells after 7 days of culture (75 of 95 wells seeded). By contrast, progenitors infected with the p16 Ink4a virus either did not prolifer- Arf virus. In contrast with the wild-type HSCs, these cells were viable 2 days after infection (Fig. 4) . These results suggest that Bmi-1 targets p16
Ink4a to allow the proliferation of HSCs and p19 Arf to inhibit apoptosis through p53.
HSCs undergo self-renewing cell divisions for the lifetime of an animal. Once an HSC has undergone cell division, the daughter cells must choose one of three possible fates: to remain as a stem cell, to differentiate into progenitors or to undergo apoptosis (Fig. 5) . Although several genes have been shown to be important for stem cell function, the mechanisms that regulate the self-renewal of HSCs are poorly understood [20] [21] [22] [23] [24] [25] [26] . Our results suggest that Bmi-1 is necessary for efficient self-renewing cell divisions of adult HSCs but is less critical for the generation of differentiated progeny (Fig. 5) . Transplantation of Bmi-1 2/2 fetal liver cells resulted in transient haematopoietic cell reconstitution. This indicates that the transplanted mutant fetal liver HSCs might not have generated HSCs efficiently but might have given rise to MPPs that could sustain haematopoiesis for only 4-8 weeks. This could have been due to the expression of other PcG genes by the MPPs. Consistent with this model was our previous result that MPPs express more Enx-1 than do HSCs 5 . Similarly, other PcG genes, such as rae28, whose expression is necessary for fetal liver haematopoiesis to occur 27 , might permit HSC proliferation in the fetus of the mutant mice. This is consistent with the observation that the expression of p19
Arf is elevated in adult bone marrow cells, but not in fetal liver cells, of the mutant mice ( Supplementary Fig. 5) . Alternatively, the number of self-renewing cell division of Bmi-1 2/2 FL-HSCs might be restricted.
The mechanism by which Bmi-1 modulates HSC self-renewal seems to be through the regulation of genes important for stem cell fate decisions as well as that of survival genes, anti-proliferative genes and stem-cell-associated genes. The gene expression data and retroviral infection experiments implicate p16
Ink4a
, p19
Arf and p53 as downstream effectors of Bmi-1 involved in the control of the proliferation and survival of HSCs during self-renewing cell divisions (Fig. 5) . However, owing to the paucity of HSCs in the Bmi-1 2/2 mice, it is not possible to determine whether the expression levels of these genes are comparable to those of HSCs infected with the p16 Ink4a and p19 Arf retroviruses. Although the increased expression of the p53-target gene Wig1 suggests that p19
Arf is activated in Bmi-1 2/2 haematopoietic cells, the relative contribution of each of these pathways to the regulation of selfrenewing HSC generation awaits careful analysis of the HSCs of Bmi-1 2/2 mice that also harbour mutations of one or more of these other genes. Some of the other genes identified in the microarray analysis might also have crucial roles in stem cell biology. For example, Wig1 and apoptosis inhibitor 6 might regulate the survival of HSCs. As Bmi-1 has now been shown 30 to be necessary for the maintenance of mouse leukaemia and Bmi-1 is expressed by human AML stem cells, it will be of interest to determine whether Bmi-1 has a similar function in human leukaemia.
A
Methods

Flow cytometry
Bone marrow cells were obtained by flushing the tibias and femurs of mice, and stained with antibodies against lineage markers (CD3, CD4, CD5, CD8, Gr-1, Mac-1 and Ter119), Sca-1, c-Kit and Thy1. 
Competitive reconstitution
Lethally irradiated C57Bl/Ka-Ly5.2 congenic mice were competitively reconstituted with whole bone marrow or E14.5 fetal liver cells from Bmi-1 
Retroviral gene transfer of HSCs
Mouse stem cell viruses expressing mouse p16 Ink4a or p19 Arf cDNAs together with GFP were produced using Phoenix ecotropic packaging cells 28 . Infection of HSCs was done as described 29 except that three cycles of infections were performed. After 48 h, single GFP-positive cells were sorted into a 96-well plate containing 100 ml HSC medium 29 and grown for 7 days. Each well was scored for the presence of GFP-positive cells by observation with a fluorescence microscope.
Mutations in the Saccharomyces cerevisiae gene SRS2 result in the yeast's sensitivity to genotoxic agents, failure to recover or adapt from DNA damage checkpoint-mediated cell cycle arrest, slow growth, chromosome loss, and hyper-recombination 1,2 . Furthermore, double mutant strains, with mutations in DNA helicase genes SRS2 and SGS1, show low viability that can be overcome by inactivating recombination, implying that untimely recombination is the cause of growth impairment 1, 3, 4 . Here we clarify the role of SRS2 in recombination modulation by purifying its encoded product and examining its interactions with the Rad51 recombinase. Srs2 has a robust ATPase activity that is dependent on single-stranded DNA (ssDNA) and binds Rad51, but the addition of a catalytic quantity of Srs2 to Rad51-mediated recombination reactions causes severe inhibition of these reactions. We show that Srs2 acts by dislodging Rad51 from ssDNA. Thus, the attenuation of recombination efficiency by Srs2 stems primarily from its ability to dismantle the Rad51 presynaptic filament efficiently. Our findings have implications for the basis of Bloom's and Werner's syndromes, which are caused by mutations in DNA helicases and are characterized by increased frequencies of recombination and a predisposition to cancers and accelerated ageing 5 . We have been unable to overexpress Srs2 protein significantly in yeast, suggesting that this protein is unstable in, and/or toxic to, yeast cells. We therefore turned to Escherichia coli and an inducible T7 promoter as vehicle for Srs2 expression. Srs2 could be revealed by Coomassie Blue staining of E. coli extracts and by immunoblotting with antibodies against Srs2 (Fig. 1a) . We subjected E. coli lysate to precipitation with ammonium sulphate and a five-step chromatographic fractionation scheme to purify Srs2 to near-homogeneity (Fig. 1b) . Purified Srs2 has a robust ssDNA-dependent ATPase activity (k cat $ 2,500 min 21 ) and a DNA helicase activity 6 that is fuelled by ATP hydrolysis (Fig. 1c) .
Previous studies have unveiled an anti-recombination function in SRS2 and a genetic interaction with RAD51 (refs 7-9). We investigated whether Srs2 protein interacts physically with Rad51 protein, and also tested its effect on the Rad51 recombinase activity 10 . To letters to nature
